Prism marketview showcases aclarion: disrupting chronic pain treatment with nociscan ai technology

New york, sept. 13, 2024 (globe newswire) -- prism marketview presents an exclusive q&a with brent ness, ceo and director of aclarion, inc. (nasdaq: acon).

ACON Ratings Summary

ACON Quant Ranking